Medicare Mulls Payment Adjustments for US Made N95s, Seeks Comments
The US agency is considering two approaches: lump-sum payments and claims-based
Executive Summary
The Centers for Medicare and Medicare Services is considering payment adjustments to hospitals for domestic N95 respirator masks to compensate for the added costs facilities incurred to acquire the face coverings during the pandemic.
You may also be interested in...
No Longer In Short Supply: US FDA Pulls N95s From Shortage List
The US FDA has removed N95s respirator masks from its medical device shortage list, citing increased domestic production.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
FDA Takes Another Swing At Banning Electrical Shock Devices
The US FDA wants to ban devices that use an electrical shock to stop aggressive behavior. The agency attempted to ban the devices in 2020 but failed after it was challenged in court.